Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT late-effects working party retrospective data

Bone Marrow Transplantation

Volumn 23, Issue 10, 1999, Pages 1043-1047

  Cohen, A ^a   Duell, T ^g   Socie G ^b   Van Lint, M T ^g   Weiss, M ^g   Tichelli, A ^c   Rovelli, A ^d   Apperley, J F ^e   Ljungman, P ^f   Kolb, H J ^g  

^a G GASLINI INSTITUTE   (Italy)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITY OF GENOA   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g NONE

Author keywords

Bone marrow transplantation; Growth; Irradiation; Leukaemia; Nutrition; Severe aplastic anaemia

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BODY HEIGHT; BODY MASS; BONE MARROW TRANSPLANTATION; CHILD; CHILD GROWTH; EPIPHYSIS; GONADAL DISEASE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID DISEASE; WHOLE BODY RADIATION;

EID: 0033008612     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701769     Document Type: Article

References (23)

1. Fagioli F, Bacigalupo A, Frassoni F et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis. Bone Marrow Transplant 1994; 13: 247-252.
2. Gratwohl A, Passweg J, Baldomero H, Hermans J. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1998; 22: 227-240.
3. Bacigalupo A, van-Lint MT, Frassoni F et al. Late complications of allogeneic bone marrow transplantation. Med Oncol Tumor Pharmacother 1991; 8: 261-263.
4. Kolb HJ, Bender-Goetze C. Late complications after allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1990; 6: 61-72.
5. Deeg HJ. Delayed complications and long-term effects after bone marrow transplantation. Hematol Oncol Clin North Am 1990; 4: 641-657.
6. Schmidt GM, Niland JC, Forman JS et al. Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Transplantation 1993; 55: 551-557.
7. Storb R, Thomas Ed, Buckner CD et al. Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long-term survivors. Blood 1976; 48: 485-490.
8. Deeg HJ, Sanders JE, Martin P et al. Secondary malignancies after marrow transplantation. Exp Hematol 1984; 12: 660-666.
9. Socié G, Kolb HJ, Ljungman P. Malignant diseases after allogeneic bone marrow transplantation: the case for assessment of risk factors. Br J Haematol 1992; 80: 427-430.
10. Socié G, Henry-Amar M, Bacigalupo A et al. Malignant tumors occurring after treatment of aplastic anemia. New Engl J Med 1993; 329: 1152-1157.
11. Uderzo C, Van Lint MT, Rovelli A et al. Papillary thyroid carcinoma after total body irradiation. Arch Dis Child 1994; 71: 256-258.
12. Cohen A, Rovelli A, van Lint MT et al. Final height of patients who underwent bone marrow transplantation during childhood. Arch Dis Child 1996; 74: 437-440.
13. Cohen A, van-Lint MT, Lavagetto A et al. Growth pattern in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 343-348.
14. Sanders JE, Pritchard S, Mahoney P et al. Growth and development for bone marrow transplantation for leukemia. Blood 1986; 69: 1129-1135.
15. Sanders J. The impact of marrow transplant preparative regimen on subsequent growth and development. Semin Hematol 1991; 28: 244-249.
16. Shinohara O, Kato S, Yabe H et al. Growth after bone marrow transplantation in children. Am J Pediatr Hematol Oncol 1991; 13: 263-268.
17. Wingard JR, Plotnick LP, Freemer CS et al. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992; 79: 1068-1073.
18. Tichelli A, Duell T, Weiss M et al for the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. Bone Marrow Transplant 1996; 17: 1105-1111.
19. Duell T, van-Lint MT, Ljungman P et al. Health and functional status of long term survivors of bone marrow transplantation - a study of the Late Effects Working Party of the European Bone and Marrow Transplantation. Ann Intern Med 1997; 126: 184-192.
20. Tanner JM, Davies PSW. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stage of puberty. Arch Dis Child 1976; 51: 170-179.
21. Burton BT, Foster WR, Hirsch J, Van Itallie TB. Report of conference proceeding health implication of obesity: an NIH consensus development conference. Int J Obes 1985; 9: 155-170.
22. Hammer LD, Kraemer HC, Wilson DM et al. Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child 1991; 145: 259-263.
23. Sklar C, Mertens A, Walter A et al. Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr 1993; 123: 59-64.